At the news
? BEARISHIMPACT 5/10 COURT-RULING filed Jun 30, 2026 at 20:00 ET
The Eighth Circuit affirmed denial of Novartis's preliminary injunction against Missouri's S.B. 751, which prohibits drug manufacturers from restricting 340B drug deliveries to contract pharmacies. This ruling upholds a growing trend of state laws limiting manufacturers' ability to control distribution, increasing compliance costs and reducing profitability of the 340B program for Novartis.
- Eighth Circuit upheld district court's denial of Novartis's preliminary injunction against Missouri S.B. 751.
- S.B. 751 prohibits drug manufacturers from restricting delivery of 340B drugs to contract pharmacies of covered entities.
- Court found Novartis unlikely to succeed on dormant Commerce Clause and preemption claims.
- 22 states have enacted similar laws, creating a patchwork of regulatory requirements.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access